Guest: William J. Sandborn, MD

IBD is a chronic gastrointestinal condition characterized by recurring disease activity. Treatment approaches for IBD vary depending on disease type and severity and patient risk profile. An accurate diagnosis combined with severity and risk assessments at appropriate intervals are essential for optimal management of IBD. Despite guidance from AGA and ACG, however, clinicians demonstrate considerable variation in their approaches to both risk assessment and care for patients with IBD. This activity will address severity and risk assessment, appropriate treatment, and patient communication.